The International Drug Policy Academy (IDPA), established by the Council of Europe's Pompidou Group, is dedicated to enhancing the capabilities of professionals involved in drug policy and addiction services. With over 50 years of international cooperation and capacity building, the IDPA aims to bridge the gap between policy, research, and practice across various sectors, fostering the development of coherent and sustainable drug policies.  

Objectives of the IDPA

• Capacity Building: Strengthening the skills of professionals for effective design, management and evaluation of drug...

CSUCH’s data visualisation tool can be used to estimate substance use trends across the country. The data helps inform programs, practices, and research to protect communities, save lives, and improve the well-being of people in Canada.

Spotlight: Top 3 causes of death due to substance use in Canada 

More than 200 people died each day due to substance use (SU) in 2020 (the latest year for which data are available). That works out to 73,994 deaths that year. The average age of death due to SU was 45 years. Tobacco use caused 63% (46,366) of SU-related deaths, followed by alcohol at 23%...

Resumen

Introducción: el consumo de cannabis ha aumentado significativamente durante las últimas décadas, sin embargo el conocimiento alrededor del consumo simultáneo de esta sustancia y alcohol es escaso.

Objetivo: explorar la prevalencia, los efectos y situaciones de riesgo relacionados con el consumo simultáneo de alcohol y cannabis, con un enfoque particular en México.

Método: para esta revisión narrativa se realizó una búsqueda en la base de datos PubMed con los términos “alcohol”, “cannabis”, “marihuana”, “co-use” y “simultaneous use”. Se seleccionó la literatura relevante y se...

Addiction and obesity share similar neurological pathways, both linked to compulsive behaviors and the brain's reward system. Research has highlighted the potential of GLP-1 receptor agonists, originally developed for diabetes, to help manage both appetite and addictive cravings. These medications, such as semaglutide, may regulate addictive behaviors by influencing reward circuits in the brain. However, they come with potential side effects, and their long-term effects are still under investigation.

In addition, a new compound, 5-Methoxy-2-aminoindane (MEAI), is being researched for its...